Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
Spain flag Spain · Delayed Price · Currency is EUR
59.00
+0.40 (0.68%)
Aug 7, 2026, 1:45 PM CET

BME:ROVI Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
177.2795.94147.7220.22257.97182.63
Depreciation & Amortization
25.449.69.4110.2322.8721.36
Stock-Based Compensation
-----1.4
Other Adjustments
-17.89-72.85-98.6519.040.14-4.78
Change in Receivables
-37.29-2.146.28-29.05-26.82-74.19
Changes in Inventories
29.6755.71-12.252.93-71.59-23.43
Changes in Accounts Payable
10.8219.5472.6295.5141.6735.36
Changes in Income Taxes Payable
-5.05-40.22-43.25-40.19-43.89-23.86
Changes in Other Operating Activities
46.7223.4521.4529.7157.2634.94
Operating Cash Flow
167.6444.5251.6754.2237.6149.44
Operating Cash Flow Growth
164.28%-13.84%-4.68%-77.19%58.99%218.80%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-45.87-8.16-3.39-5.5-50.72-40.22
Sale of Property, Plant & Equipment
-0.180.020.10.080.03
Purchases of Intangible Assets
-2.18-0.78-2.65-0.49-0.67-0.72
Purchases of Investments
--52.09-32.03-8.88-5.87-
Proceeds from Sale of Investments
-2.544.0658.710.02-
Cash Acquisitions
-24.13-43.14-26-2.89--
Proceeds from Business Divestments
-1.83.7757.93--
Other Investing Activities
0.960.550.110.520.010.07
Investing Cash Flow
-79.25-49.55-28.0549.76-57.15-40.84

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
1.09218.41215.1912.71.41.34
Long-Term Debt Repaid
-21.35-40.07-46.88-27.99-6.77-6.19
Net Long-Term Debt Issued (Repaid)
-20.26178.34168.31-15.29-5.37-4.85
Issuance of Common Stock
55.1936.34--77.7742.33
Repurchase of Common Stock
-55.65-0.02-95.57-162.52-177.01-78.79
Net Common Stock Issued (Repurchased)
-0.4636.32-95.57-162.52-99.24-36.46
Common Dividends Paid
--95.66-112.9-138.1-51.01-21.13
Other Financing Activities
4.1236.34--0.391.08-0.29
Financing Cash Flow
53.1377.67-20.08-158.15-154.54-62.73

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
82.7172.643.53-54.1925.9145.87

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
121.7736.3648.2848.7186.88109.22
Free Cash Flow Growth
326.94%-24.69%-0.87%-73.94%71.10%1348.77%
FCF Margin
15.75%4.89%6.32%5.87%22.85%16.84%
Free Cash Flow Per Share
2.380.710.940.923.501.97
Levered Free Cash Flow
226.66378.7349.79247.73149.9152.38
Unlevered Free Cash Flow
167.81202.26182.8262.77153.62156.35